PubRank

David J Pinsky

Author PubWeight™ 75.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome. Am J Med 2011 2.59
2 Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2006 2.47
3 Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A 2004 2.42
4 Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest 2007 1.87
5 Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis. J Am Coll Cardiol 2007 1.64
6 Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res 2006 1.63
7 Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2010 1.58
8 Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. J Immunol 2008 1.42
9 Timing of nitric oxide donor supplementation determines endothelin-1 regulation and quality of lung preservation for transplantation. Am J Respir Cell Mol Biol 2002 1.41
10 Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost 2005 1.32
11 Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Am J Cardiol 2007 1.32
12 Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction. Am Heart J 2006 1.31
13 Brain injury and neurofunctional deficit in neonatal mice with hypoxic-ischemic encephalopathy. Behav Brain Res 2003 1.31
14 Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. J Pharmacol Exp Ther 2003 1.29
15 Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha. FASEB J 2006 1.24
16 Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J Clin Invest 2009 1.22
17 Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care 2002 1.16
18 Carbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes. Proc Natl Acad Sci U S A 2006 1.14
19 Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol. Psychopharmacology (Berl) 2008 1.13
20 Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. FASEB J 2002 1.13
21 Obligatory role for interleukin-13 in obstructive lesion development in airway allografts. Am J Pathol 2006 1.11
22 cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression. J Biol Chem 2010 1.11
23 Late measures of brain injury after neonatal hypoxia-ischemia in mice. Stroke 2004 1.10
24 Targeting therapeutics to the vascular wall in atherosclerosis--carrier size matters. Atherosclerosis 2011 1.09
25 COX inhibitors and thromboregulation. N Engl J Med 2002 1.08
26 Heterotopic vascularized murine cardiac transplantation to study graft arteriopathy. Nat Protoc 2007 1.02
27 Ecto-5' nucleotidase (CD73)-mediated adenosine generation and signaling in murine cardiac allograft vasculopathy. Circ Res 2008 1.01
28 Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography. Arterioscler Thromb Vasc Biol 2007 1.01
29 Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography. Atherosclerosis 2009 0.98
30 Epithelial interactions and local engraftment of lung-resident mesenchymal stem cells. Am J Respir Cell Mol Biol 2011 0.98
31 PKCbeta regulates ischemia/reperfusion injury in the lung. J Clin Invest 2004 0.98
32 Suppression of murine cardiac allograft arteriopathy by long-term blockade of CD40-CD154 interactions. Circulation 2002 0.98
33 Reciprocal regulation of airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase. J Exp Med 2005 0.96
34 Neuronal RAGE expression modulates severity of injury following transient focal cerebral ischemia. J Clin Neurosci 2008 0.96
35 Early growth response 1 mediates the systemic and hepatic inflammatory response initiated by hemorrhagic shock. Shock 2007 0.96
36 Temporal pattern of C1q deposition after transient focal cerebral ischemia. J Neurosci Res 2006 0.96
37 Recipient iNOS but not eNOS deficiency reduces luminal narrowing in tracheal allografts. J Exp Med 2002 0.95
38 C1q-deficiency is neuroprotective against hypoxic-ischemic brain injury in neonatal mice. Stroke 2005 0.95
39 Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography. Coron Artery Dis 2009 0.95
40 Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation. J Immunol 2010 0.93
41 Enhanced fibrinolysis protects against lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2009 0.91
42 Riboflavin-mediated reduction of oxidant injury, rejection, and vasculopathy after cardiac allotransplantation. Transplantation 2007 0.90
43 Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography. Am J Cardiol 2006 0.90
44 Increased CD39 nucleotidase activity on microparticles from patients with idiopathic pulmonary arterial hypertension. PLoS One 2012 0.89
45 Platelet activation in the postoperative period after lung transplantation. J Thorac Cardiovasc Surg 2008 0.88
46 Tissue-resident ecto-5' nucleotidase (CD73) regulates leukocyte trafficking in the ischemic brain. J Immunol 2012 0.86
47 HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke. Circ Res 2002 0.86
48 A cerebroprotective dose of intravenous citrate/sorbitol-stabilized dehydroascorbic acid is correlated with increased cerebral ascorbic acid and inhibited lipid peroxidation after murine reperfused stroke. Neurosurgery 2006 0.83
49 TLR signaling prevents hyperoxia-induced lung injury by protecting the alveolar epithelium from oxidant-mediated death. J Immunol 2012 0.83
50 Influence of ischemic injury on vein graft remodeling: role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation. J Thorac Cardiovasc Surg 2005 0.83
51 Transcriptional control of cardiac allograft vasculopathy by early growth response gene-1 (Egr-1). Circ Res 2002 0.83
52 Pulmonary artery smooth muscle hypertrophy: roles of glycogen synthase kinase-3beta and p70 ribosomal S6 kinase. Am J Physiol Lung Cell Mol Physiol 2010 0.83
53 Interhemispheric intracranial pressure gradients in nonhuman primate stroke. Surg Neurol 2002 0.82
54 Baseline plasma adiponectin levels as a predictor of left ventricular systolic dysfunction in patients referred for coronary angiography. Am J Cardiol 2008 0.82
55 Early growth response gene-1 promotes airway allograft rejection. Am J Physiol Lung Cell Mol Physiol 2007 0.82
56 Ultrarapid, convection-enhanced intravascular hypothermia: a feasibility study in nonhuman primate stroke. Stroke 2003 0.82
57 Suppression of inflammatory cell trafficking and alveolar simplification by the heme oxygenase-1 product carbon monoxide. Am J Physiol Lung Cell Mol Physiol 2014 0.81
58 Myeloid mineralocorticoid receptor during experimental ischemic stroke: effects of model and sex. J Am Heart Assoc 2012 0.81
59 Regulation of ecto-apyrase CD39 (ENTPD1) expression by phosphodiesterase III (PDE3). FASEB J 2013 0.81
60 Flow-dependent expression of ectonucleotide tri(di)phosphohydrolase-1 and suppression of atherosclerosis. J Clin Invest 2015 0.80
61 Endothelial Cx40 limits myocardial ischaemia/reperfusion injury in mice. Cardiovasc Res 2014 0.79
62 Suppression of nitrosative and oxidative stress to reduce cardiac allograft vasculopathy. Am J Physiol Heart Circ Physiol 2009 0.79
63 Pre-clinical evaluation of an sLe x-glycosylated complement inhibitory protein in a non-human primate model of reperfused stroke. J Med Primatol 2007 0.79
64 Preclinical evaluation of the neuroprotective effect of soluble complement receptor type 1 in a nonhuman primate model of reperfused stroke. J Neurosurg 2006 0.78
65 CD39: Interface between vascular thrombosis and inflammation. Curr Atheroscler Rep 2014 0.78
66 Relation of baseline plasma phospholipid levels to cardiovascular outcomes at two years in men with acute coronary syndrome referred for coronary angiography. Am J Cardiol 2007 0.78
67 Paradoxical exacerbation of neuronal injury in reperfused stroke despite improved blood flow and reduced inflammation in early growth response-1 gene-deleted mice. Neurol Res 2011 0.78
68 Alive and kicking: endothelium at the geographic nexus of vascular rejection. Circ Res 2002 0.77
69 Antioxidant properties of pioglitazone limit nicotinamide adenine dinucleotide phosphate hydrogen oxidase and augment superoxide dismutase activity in cardiac allotransplantation. J Heart Lung Transplant 2011 0.76
70 Usefulness of the serum complement component C4 as a predictor of stroke in patients with known or suspected coronary artery disease referred for coronary angiography. Am J Cardiol 2007 0.76
71 Preclinical evaluation of postischemic dehydroascorbic Acid administration in a large-animal stroke model. Transl Stroke Res 2011 0.75
72 Relation of baseline serum potassium levels to angiographic findings in patients with known or suspected coronary artery disease. Am J Hypertens 2009 0.75